Gesundheit
Branchen-Index
Biotechnologie (Forschung)-Aktien
Vollständige Übersicht aller 407 börsennotierten Unternehmen der Branche Biotechnologie (Forschung). Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Unternehmen
407
100 % erfasst
Gesamtkapitalisierung
1,70 Bio. $
Gesamtwert
Median-KGV
5,9
Bewertungsniveau
Ø Insider-Score
39,3
Conviction-Skala 0–100
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | AKTX Akari Therapeutics Plc | 989,0 Mrd. $ Mega Cap | 8,23 $ | — | — | 45 | Details › |
| 2 | TMO THERMO FISHER SCIENTIFIC INC. | 243,2 Mrd. $ Mega Cap | 673,82 $ | 38,1 | 0,3 % | 59 | Details › |
| 3 | RVMD Revolution Medicines, Inc. | 39,5 Mrd. $ Mega Cap | 187,10 $ | — | — | 53 | Details › |
| 4 | ROIV Roivant Sciences Ltd. | 23,8 Mrd. $ Mega Cap | 36,74 $ | — | — | 41 | Details › |
| 5 | GMAB GENMAB A/S | 22,7 Mrd. $ Mega Cap | 39,83 $ | 25,7 | — | 51 | Details › |
| 6 | BNTX BioNTech SE | 21,9 Mrd. $ Mega Cap | 88,60 $ | — | — | 60 | Details › |
| 7 | HALO HALOZYME THERAPEUTICS, INC. | 12,6 Mrd. $ Mega Cap | 125,63 $ | 48,6 | — | 54 | Details › |
| 8 | BBIO BridgeBio Pharma, Inc. | 12,6 Mrd. $ Mega Cap | 68,51 $ | — | — | 36 | Details › |
| 9 | TECH BIO-TECHNE Corp | 11,4 Mrd. $ Mega Cap | 72,55 $ | 62,6 | 0,4 % | 52 | Details › |
| 10 | PCVX Vaxcyte, Inc. | 9,9 Mrd. $ Large Cap | 61,94 $ | — | — | 32 | Details › |
| 11 | IBRX ImmunityBio, Inc. | 9,6 Mrd. $ Large Cap | 8,22 $ | — | — | 34 | Details › |
| 12 | KYMR Kymera Therapeutics, Inc. | 9,1 Mrd. $ Large Cap | 110,41 $ | — | — | 41 | Details › |
| 13 | KRYS Krystal Biotech, Inc. | 8,9 Mrd. $ Large Cap | 312,96 $ | 45,8 | — | 63 | Details › |
| 14 | PTGX Protagonist Therapeutics, Inc | 8,8 Mrd. $ Large Cap | 138,43 $ | — | — | 34 | Details › |
| 15 | AXSM Axsome Therapeutics, Inc. | 8,1 Mrd. $ Large Cap | 145,04 $ | — | — | 31 | Details › |
| 16 | TWST Twist Bioscience Corp | 8,0 Mrd. $ Large Cap | 133,26 $ | — | — | 39 | Details › |
| 17 | SYRE Spyre Therapeutics, Inc. | 7,4 Mrd. $ Large Cap | 89,64 $ | — | — | 33 | Details › |
| 18 | PRAX Praxis Precision Medicines, Inc. | 6,5 Mrd. $ Large Cap | 255,02 $ | — | — | 26 | Details › |
| 19 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | 6,1 Mrd. $ Large Cap | 14,09 $ | — | — | 29 | Details › |
| 20 | KOD Kodiak Sciences Inc. | 5,6 Mrd. $ Large Cap | 87,63 $ | — | — | 27 | Details › |
| 21 | CGON CG Oncology, Inc. | 5,4 Mrd. $ Large Cap | 61,05 $ | — | — | 35 | Details › |
| 22 | ORKA Oruka Therapeutics, Inc. | 5,3 Mrd. $ Large Cap | 80,15 $ | — | — | 41 | Details › |
| 23 | GOSS Gossamer Bio, Inc. | 5,0 Mrd. $ Large Cap | 9,04 $ | — | — | 16 | Details › |
| 24 | COGT Cogent Biosciences, Inc. | 5,0 Mrd. $ Large Cap | 30,85 $ | — | — | 51 | Details › |
| 25 | SRRK Scholar Rock Holding Corp | 5,0 Mrd. $ Large Cap | 41,19 $ | — | — | 42 | Details › |
| 26 | CRSP CRISPR Therapeutics AG | 4,5 Mrd. $ Large Cap | 48,11 $ | — | — | 43 | Details › |
| 27 | DNTH Dianthus Therapeutics, Inc. /DE/ | 4,4 Mrd. $ Large Cap | 76,97 $ | — | — | 30 | Details › |
| 28 | TNGX Tango Therapeutics, Inc. | 4,0 Mrd. $ Large Cap | 24,27 $ | — | — | 30 | Details › |
| 29 | RLAY Relay Therapeutics, Inc. | 4,0 Mrd. $ Large Cap | 18,12 $ | — | — | 41 | Details › |
| 30 | EWTX Edgewise Therapeutics, Inc. | 3,9 Mrd. $ Large Cap | 38,90 $ | — | — | 45 | Details › |
| 31 | RGC Regencell Bioscience Holdings Ltd | 3,7 Mrd. $ Large Cap | 8,85 $ | — | — | 32 | Details › |
| 32 | PBLS Parabilis Medicines, Inc. | 3,7 Mrd. $ Large Cap | 24,44 $ | — | — | 40 | Details › |
| 33 | ABCL AbCellera Biologics Inc. | 3,4 Mrd. $ Large Cap | 11,35 $ | — | — | 32 | Details › |
| 34 | LEGN Legend Biotech Corp | 3,4 Mrd. $ Large Cap | 19,03 $ | — | — | 50 | Details › |
| 35 | IDYA IDEAYA Biosciences, Inc. | 3,3 Mrd. $ Large Cap | 35,29 $ | — | — | 46 | Details › |
| 36 | XENE Xenon Pharmaceuticals Inc. | 3,3 Mrd. $ Large Cap | 35,67 $ | — | — | 45 | Details › |
| 37 | CELC Celcuity Inc. | 3,2 Mrd. $ Large Cap | 64,51 $ | — | — | 33 | Details › |
| 38 | DYN Dyne Therapeutics, Inc. | 2,9 Mrd. $ Large Cap | 15,57 $ | — | — | 48 | Details › |
| 39 | RCUS Arcus Biosciences, Inc. | 2,9 Mrd. $ Large Cap | 18,50 $ | — | — | 41 | Details › |
| 40 | IRON Disc Medicine, Inc. | 2,9 Mrd. $ Large Cap | 74,91 $ | — | — | 37 | Details › |
| 41 | ELVN Enliven Therapeutics, Inc. | 2,9 Mrd. $ Large Cap | 40,99 $ | — | — | 42 | Details › |
| 42 | DNLI Denali Therapeutics Inc. | 2,8 Mrd. $ Large Cap | 18,19 $ | — | — | 38 | Details › |
| 43 | VKTX Viking Therapeutics, Inc. | 2,8 Mrd. $ Large Cap | 24,51 $ | — | — | 28 | Details › |
| 44 | DBVT DBV Technologies S.A. | 2,8 Mrd. $ Large Cap | 9,68 $ | — | — | 26 | Details › |
| 45 | NRIX Nurix Therapeutics, Inc. | 2,4 Mrd. $ Large Cap | 25,34 $ | — | — | 50 | Details › |
| 46 | BEAM Beam Therapeutics Inc. | 2,4 Mrd. $ Large Cap | 23,58 $ | — | — | 37 | Details › |
| 47 | PGEN PRECIGEN, INC. | 2,4 Mrd. $ Large Cap | 6,19 $ | — | — | 43 | Details › |
| 48 | SLS SELLAS Life Sciences Group, Inc. | 2,4 Mrd. $ Large Cap | 11,54 $ | — | — | 37 | Details › |
| 49 | MBX MBX Biosciences, Inc. | 2,3 Mrd. $ Large Cap | 48,50 $ | — | — | 46 | Details › |
| 50 | BHVN Biohaven Ltd. | 2,2 Mrd. $ Large Cap | 14,08 $ | — | — | 35 | Details › |
| 51 | VCEL Vericel Corp | 2,1 Mrd. $ Large Cap | 42,53 $ | 134,3 | — | 62 | Details › |
| 52 | FTRE Fortrea Holdings Inc. | 2,1 Mrd. $ Large Cap | 23,56 $ | — | — | 35 | Details › |
| 53 | VRDN Viridian Therapeutics, Inc.\DE | 2,1 Mrd. $ Large Cap | 22,27 $ | — | — | 40 | Details › |
| 54 | CLDX Celldex Therapeutics, Inc. | 2,1 Mrd. $ Large Cap | 29,25 $ | — | — | 32 | Details › |
| 55 | LKFT Lakefront Biotherapeutics NV | 2,0 Mrd. $ Large Cap | 31,65 $ | 6,3 | — | 60 | Details › |
| 56 | ZYME Zymeworks Inc. | 2,0 Mrd. $ Large Cap | 28,26 $ | — | — | 34 | Details › |
| 57 | ADRX ADARx Pharmaceuticals, Inc. | 2,0 Mrd. $ Mid Cap | 17,63 $ | — | — | — | Details › |
| 58 | VERA Vera Therapeutics, Inc. | 2,0 Mrd. $ Mid Cap | 28,90 $ | — | — | 46 | Details › |
| 59 | XNCR Xencor Inc | 1,8 Mrd. $ Mid Cap | 25,18 $ | — | — | 40 | Details › |
| 60 | ZBIO Zenas BioPharma, Inc. | 1,8 Mrd. $ Mid Cap | 26,87 $ | — | — | 43 | Details › |
| 61 | BRVE Braveheart Bio, Inc. | 1,8 Mrd. $ Mid Cap | 21,44 $ | — | — | — | Details › |
| 62 | MLYS Mineralys Therapeutics, Inc. | 1,8 Mrd. $ Mid Cap | 20,83 $ | — | — | 27 | Details › |
| 63 | MESO MESOBLAST LTD | 1,7 Mrd. $ Mid Cap | 12,28 $ | — | — | 36 | Details › |
| 64 | SEPN Septerna, Inc. | 1,7 Mrd. $ Mid Cap | 40,41 $ | — | — | 58 | Details › |
| 65 | VIR Vir Biotechnology, Inc. | 1,7 Mrd. $ Mid Cap | 10,08 $ | — | — | 43 | Details › |
| 66 | RXRX RECURSION PHARMACEUTICALS, INC. | 1,7 Mrd. $ Mid Cap | 3,53 $ | — | — | 19 | Details › |
| 67 | MAZE Maze Therapeutics, Inc. | 1,6 Mrd. $ Mid Cap | 31,01 $ | — | — | 40 | Details › |
| 68 | COAG Hemab Therapeutics Holdings, Inc. | 1,6 Mrd. $ Mid Cap | 34,40 $ | — | — | 43 | Details › |
| 69 | NUVB Nuvation Bio Inc. | 1,6 Mrd. $ Mid Cap | 4,52 $ | — | — | 30 | Details › |
| 70 | AZTA Azenta, Inc. | 1,6 Mrd. $ Mid Cap | 36,50 $ | — | — | 38 | Details › |
| 71 | NTLA Intellia Therapeutics, Inc. | 1,5 Mrd. $ Mid Cap | 10,61 $ | — | — | 31 | Details › |
| 72 | IMCR Immunocore Holdings plc | 1,5 Mrd. $ Mid Cap | 31,37 $ | — | — | 46 | Details › |
| 73 | GENB Generate Biomedicines, Inc. | 1,5 Mrd. $ Mid Cap | 12,41 $ | — | — | 36 | Details › |
| 74 | CMPS COMPASS Pathways plc | 1,5 Mrd. $ Mid Cap | 11,20 $ | — | — | 39 | Details › |
| 75 | TRAX First Tracks Biotherapeutics, Inc. | 1,4 Mrd. $ Mid Cap | 44,05 $ | — | — | 53 | Details › |
| 76 | ABSI Absci Corp | 1,4 Mrd. $ Mid Cap | 9,27 $ | — | — | 49 | Details › |
| 77 | QURE uniQure N.V. | 1,4 Mrd. $ Mid Cap | 22,43 $ | — | — | 39 | Details › |
| 78 | INBX Inhibrx Biosciences, Inc. | 1,3 Mrd. $ Mid Cap | 94,31 $ | — | — | 21 | Details › |
| 79 | NKTR NEKTAR THERAPEUTICS | 1,3 Mrd. $ Mid Cap | 37,22 $ | — | — | 33 | Details › |
| 80 | LTGO Latigo Biotherapeutics, Inc. | 1,3 Mrd. $ Mid Cap | 15,02 $ | — | — | — | Details › |
| 81 | OMER OMEROS CORP | 1,2 Mrd. $ Mid Cap | 16,57 $ | — | — | 28 | Details › |
| 82 | GHRS GH Research PLC | 1,2 Mrd. $ Mid Cap | 18,16 $ | — | — | 41 | Details › |
| 83 | KARD Kardigan, Inc. | 1,2 Mrd. $ Mid Cap | 12,80 $ | — | — | 48 | Details › |
| 84 | RAPP Rapport Therapeutics, Inc. | 1,2 Mrd. $ Mid Cap | 26,07 $ | — | — | 54 | Details › |
| 85 | DMRA Damora Therapeutics, Inc. | 1,2 Mrd. $ Mid Cap | 21,09 $ | 5,5 | — | 45 | Details › |
| 86 | SCNI Scinai Immunotherapeutics Ltd. | 1,2 Mrd. $ Mid Cap | 0,60 $ | — | — | — | Details › |
| 87 | ORIC Oric Pharmaceuticals, Inc. | 1,2 Mrd. $ Mid Cap | 13,20 $ | — | — | 28 | Details › |
| 88 | TSHA Taysha Gene Therapies, Inc. | 1,2 Mrd. $ Mid Cap | 3,85 $ | — | — | 45 | Details › |
| 89 | TYRA Tyra Biosciences, Inc. | 1,2 Mrd. $ Mid Cap | 20,42 $ | — | — | 42 | Details › |
| 90 | ANAB ANAPTYSBIO, INC | 1,2 Mrd. $ Mid Cap | 48,73 $ | — | — | 50 | Details › |
| 91 | LBRX LB PHARMACEUTICALS INC | 1,2 Mrd. $ Mid Cap | 38,73 $ | — | — | 28 | Details › |
| 92 | SLN Silence Therapeutics plc | 1,2 Mrd. $ Mid Cap | 19,67 $ | — | — | 42 | Details › |
| 93 | REPL Replimune Group, Inc. | 1,1 Mrd. $ Mid Cap | 11,64 $ | — | — | 48 | Details › |
| 94 | BCAX Bicara Therapeutics Inc. | 1,1 Mrd. $ Mid Cap | 17,07 $ | — | — | 44 | Details › |
| 95 | IMTX Immatics N.V. | 1,1 Mrd. $ Mid Cap | 7,32 $ | — | — | 39 | Details › |
| 96 | VOR Vor Biopharma Inc. | 1,1 Mrd. $ Mid Cap | 18,22 $ | — | — | 38 | Details › |
| 97 | GRML Greenland Mines Ltd | 1,0 Mrd. $ Mid Cap | 5,78 $ | — | — | 16 | Details › |
| 98 | JANX Janux Therapeutics, Inc. | 1,0 Mrd. $ Mid Cap | 16,63 $ | — | — | 26 | Details › |
| 99 | MLTX MoonLake Immunotherapeutics | 995,3 Mio. $ Mid Cap | 11,53 $ | — | — | 42 | Details › |
| 100 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | 943,3 Mio. $ Mid Cap | 7,08 $ | — | — | 45 | Details › |
| 101 | ODTX Odyssey Therapeutics, Inc. | 935,1 Mio. $ Mid Cap | 19,60 $ | — | — | 56 | Details › |
| 102 | JBIO Jade Biosciences, Inc. | 910,3 Mio. $ Mid Cap | 14,68 $ | — | — | 32 | Details › |
| 103 | MGTX MeiraGTx Holdings plc | 880,6 Mio. $ Mid Cap | 9,29 $ | — | — | 54 | Details › |
| 104 | RIGL RIGEL PHARMACEUTICALS INC | 875,9 Mio. $ Mid Cap | 48,13 $ | 2,5 | — | 75 | Details › |
| 105 | AKTS Aktis Oncology, Inc. | 866,8 Mio. $ Mid Cap | 15,73 $ | — | — | — | Details › |
| 106 | OBX Obsidian Therapeutics, Inc. | 839,5 Mio. $ Mid Cap | 13,98 $ | — | — | 28 | Details › |
| 107 | ABUS Arbutus Biopharma Corp | 824,7 Mio. $ Mid Cap | 4,20 $ | — | — | 35 | Details › |
| 108 | ARDX ARDELYX, INC. | 780,3 Mio. $ Mid Cap | 3,08 $ | — | — | 40 | Details › |
| 109 | SLBT SL Science Holding Ltd | 729,0 Mio. $ Mid Cap | 1,15 $ | — | — | — | Details › |
| 110 | ATTO Attovia Therapeutics, Inc. | 720,3 Mio. $ Mid Cap | 13,83 $ | — | — | 38 | Details › |
| 111 | PRME Prime Medicine, Inc. | 697,7 Mio. $ Mid Cap | 3,62 $ | — | — | 29 | Details › |
| 112 | SANA Sana Biotechnology, Inc. | 667,6 Mio. $ Mid Cap | 2,30 $ | — | — | 45 | Details › |
| 113 | OABI OmniAb, Inc. | 665,3 Mio. $ Mid Cap | 4,61 $ | — | — | 58 | Details › |
| 114 | AURA Aura Biosciences, Inc. | 652,5 Mio. $ Mid Cap | 6,30 $ | — | — | 55 | Details › |
| 115 | CADL Candel Therapeutics, Inc. | 641,3 Mio. $ Mid Cap | 8,06 $ | — | — | 46 | Details › |
| 116 | DNA Ginkgo Bioworks Holdings, Inc. | 622,1 Mio. $ Mid Cap | 9,77 $ | — | — | 30 | Details › |
| 117 | DSGN Design Therapeutics, Inc. | 600,4 Mio. $ Mid Cap | 10,28 $ | — | — | 54 | Details › |
| 118 | SLDB Solid Biosciences Inc. | 598,7 Mio. $ Mid Cap | 5,90 $ | — | — | 48 | Details › |
| 119 | ALMS ALUMIS INC. | 597,2 Mio. $ Mid Cap | 6,76 $ | — | — | 24 | Details › |
| 120 | IMMX Immix Biopharma, Inc. | 596,2 Mio. $ Mid Cap | 8,18 $ | — | — | 56 | Details › |
| 121 | CLYM Climb Bio, Inc. | 594,3 Mio. $ Mid Cap | 10,19 $ | — | — | 48 | Details › |
| 122 | OLMA Olema Pharmaceuticals, Inc. | 581,2 Mio. $ Mid Cap | 6,50 $ | — | — | 38 | Details › |
| 123 | STTK Shattuck Labs, Inc. | 577,8 Mio. $ Mid Cap | 5,49 $ | — | — | 45 | Details › |
| 124 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 576,7 Mio. $ Mid Cap | 2,11 $ | — | — | 31 | Details › |
| 125 | FDMT 4D Molecular Therapeutics, Inc. | 562,0 Mio. $ Mid Cap | 10,73 $ | — | — | 26 | Details › |
| 126 | ANL Adlai Nortye Group Ltd. | 539,2 Mio. $ Mid Cap | 10,49 $ | — | — | 42 | Details › |
| 127 | PBYI PUMA BIOTECHNOLOGY, INC. | 531,4 Mio. $ Mid Cap | 11,02 $ | 18,5 | — | 68 | Details › |
| 128 | FTH Faeth Therapeutics, Inc. | 530,1 Mio. $ Mid Cap | 17,08 $ | — | — | 33 | Details › |
| 129 | ACRS Aclaris Therapeutics, Inc. | 522,8 Mio. $ Mid Cap | 3,75 $ | — | — | 30 | Details › |
| 130 | CTMX CytomX Therapeutics, Inc. | 522,7 Mio. $ Mid Cap | 2,32 $ | — | — | 33 | Details › |
| 131 | EVO Evotec SE | 506,1 Mio. $ Mid Cap | 1,50 $ | — | — | 42 | Details › |
| 132 | VALN Valneva SE | 482,2 Mio. $ Mid Cap | 5,31 $ | — | — | — | Details › |
| 133 | CBIO CRESCENT BIOPHARMA, INC. | 480,0 Mio. $ Mid Cap | 12,82 $ | — | — | 37 | Details › |
| 134 | DRUG BRIGHT MINDS BIOSCIENCES INC. | 474,5 Mio. $ Mid Cap | 51,83 $ | — | — | 40 | Details › |
| 135 | BLSM BlossomHill Therapeutics, Inc. | 471,9 Mio. $ Mid Cap | 14,63 $ | — | — | — | Details › |
| 136 | RGNX REGENXBIO Inc. | 470,7 Mio. $ Mid Cap | 7,03 $ | — | — | 33 | Details › |
| 137 | MNPR Monopar Therapeutics | 455,9 Mio. $ Mid Cap | 69,80 $ | — | — | 31 | Details › |
| 138 | ARVN ARVINAS, INC. | 451,5 Mio. $ Mid Cap | 7,43 $ | — | — | 50 | Details › |
| 139 | IBO IMPACT BIOMEDICAL INC. | 446,7 Mio. $ Mid Cap | 3,60 $ | — | — | — | Details › |
| 140 | ALT Altimmune, Inc. | 442,2 Mio. $ Mid Cap | 2,12 $ | — | — | 57 | Details › |
| 141 | EIKN Eikon Therapeutics, Inc. | 435,6 Mio. $ Mid Cap | 7,26 $ | — | — | 37 | Details › |
| 142 | DMAC DiaMedica Therapeutics Inc. | 434,4 Mio. $ Mid Cap | 8,72 $ | — | — | 43 | Details › |
| 143 | ASMB ASSEMBLY BIOSCIENCES, INC. | 421,4 Mio. $ Mid Cap | 19,84 $ | — | — | 44 | Details › |
| 144 | PRTA PROTHENA CORP PUBLIC LTD CO | 419,4 Mio. $ Mid Cap | 7,97 $ | — | — | 45 | Details › |
| 145 | PHAT Phathom Pharmaceuticals, Inc. | 414,5 Mio. $ Mid Cap | 5,49 $ | — | — | 46 | Details › |
| 146 | NGNE Neurogene Inc. | 409,8 Mio. $ Mid Cap | 23,55 $ | — | — | 47 | Details › |
| 147 | OVID Ovid Therapeutics Inc. | 406,7 Mio. $ Mid Cap | 2,27 $ | — | — | 40 | Details › |
| 148 | ENTX Entera Bio Ltd. | 400,4 Mio. $ Mid Cap | 2,85 $ | 11,4 | — | 38 | Details › |
| 149 | AGMB AgomAb Therapeutics NV | 399,0 Mio. $ Mid Cap | 9,05 $ | — | — | 58 | Details › |
| 150 | ALLO Allogene Therapeutics, Inc. | 395,5 Mio. $ Mid Cap | 1,18 $ | — | — | 32 | Details › |
| 151 | AVTX Avalo Therapeutics, Inc. | 391,7 Mio. $ Mid Cap | 6,93 $ | — | — | 25 | Details › |
| 152 | TECX Tectonic Therapeutic, Inc. | 390,7 Mio. $ Mid Cap | 20,46 $ | — | — | 48 | Details › |
| 153 | NAUT Nautilus Biotechnology, Inc. | 383,5 Mio. $ Mid Cap | 3,18 $ | — | — | 45 | Details › |
| 154 | CAPR CAPRICOR THERAPEUTICS, INC. | 382,6 Mio. $ Mid Cap | 5,93 $ | — | — | 15 | Details › |
| 155 | AUTL Autolus Therapeutics plc | 382,2 Mio. $ Mid Cap | 1,52 $ | — | — | 39 | Details › |
| 156 | MPLT MapLight Therapeutics, Inc. | 380,2 Mio. $ Mid Cap | 7,97 $ | — | — | 45 | Details › |
| 157 | RLMD RELMADA THERAPEUTICS, INC. | 378,4 Mio. $ Mid Cap | 3,27 $ | — | — | 45 | Details › |
| 158 | TKNO Alpha Teknova, Inc. | 375,4 Mio. $ Mid Cap | 6,47 $ | — | — | 32 | Details › |
| 159 | CCCC C4 Therapeutics, Inc. | 365,5 Mio. $ Mid Cap | 3,10 $ | — | — | 51 | Details › |
| 160 | EDIT Editas Medicine, Inc. | 362,5 Mio. $ Mid Cap | 2,37 $ | — | — | 45 | Details › |
| 161 | GALT GALECTIN THERAPEUTICS INC | 356,9 Mio. $ Mid Cap | 3,19 $ | — | — | 62 | Details › |
| 162 | INDP Indaptus Therapeutics, Inc. | 348,1 Mio. $ Mid Cap | 3,12 $ | — | — | 25 | Details › |
| 163 | ENTA ENANTA PHARMACEUTICALS INC | 341,2 Mio. $ Mid Cap | 11,64 $ | — | — | 35 | Details › |
| 164 | KYTX Kyverna Therapeutics, Inc. | 328,8 Mio. $ Mid Cap | 5,39 $ | — | — | 38 | Details › |
| 165 | ZURA Zura Bio Ltd | 327,7 Mio. $ Mid Cap | 3,46 $ | — | — | 39 | Details › |
| 166 | CYDY CytoDyn Inc. | 318,0 Mio. $ Mid Cap | 0,26 $ | — | — | 29 | Details › |
| 167 | BNTC Benitec Biopharma Inc. | 310,3 Mio. $ Mid Cap | 8,72 $ | — | — | 35 | Details › |
| 168 | ARCT Arcturus Therapeutics Holdings Inc. | 309,2 Mio. $ Mid Cap | 10,19 $ | — | — | 36 | Details › |
| 169 | GTBP GT Biopharma, Inc. | 298,3 Mio. $ Small Cap | 5,46 $ | — | — | 30 | Details › |
| 170 | ARTV Artiva Biotherapeutics, Inc. | 296,2 Mio. $ Small Cap | 6,07 $ | — | — | 33 | Details › |
| 171 | SRZN Surrozen, Inc./DE | 289,8 Mio. $ Small Cap | 26,29 $ | — | — | 46 | Details › |
| 172 | OCGN Ocugen, Inc. | 288,0 Mio. $ Small Cap | 0,74 $ | — | — | 36 | Details › |
| 173 | PRLD Prelude Therapeutics Inc | 282,7 Mio. $ Small Cap | 3,44 $ | — | — | 49 | Details › |
| 174 | AGEN AGENUS INC | 279,6 Mio. $ Small Cap | 6,33 $ | — | — | 31 | Details › |
| 175 | QSI Quantum-Si Inc | 278,5 Mio. $ Small Cap | 1,31 $ | — | — | 40 | Details › |
| 176 | YDES YD Bio Ltd | 277,5 Mio. $ Small Cap | 4,95 $ | — | — | 35 | Details › |
| 177 | SGMT Sagimet Biosciences Inc. | 277,4 Mio. $ Small Cap | 9,58 $ | — | — | 43 | Details › |
| 178 | SABS SAB Biotherapeutics, Inc. | 272,1 Mio. $ Small Cap | 2,89 $ | — | — | 51 | Details › |
| 179 | CABA Cabaletta Bio, Inc. | 264,5 Mio. $ Small Cap | 1,43 $ | — | — | 44 | Details › |
| 180 | CYPH CYPHERPUNK TECHNOLOGIES INC. | 258,9 Mio. $ Small Cap | 2,82 $ | 42,6 | — | 32 | Details › |
| 181 | RCKT ROCKET PHARMACEUTICALS, INC. | 255,8 Mio. $ Small Cap | 2,29 $ | — | — | 44 | Details › |
| 182 | NWBO NORTHWEST BIOTHERAPEUTICS INC | 251,2 Mio. $ Small Cap | 0,15 $ | — | — | 35 | Details › |
| 183 | QTTB Q32 Bio Inc. | 249,1 Mio. $ Small Cap | 8,41 $ | 3,5 | — | 51 | Details › |
| 184 | IPSC Century Therapeutics, Inc. | 249,1 Mio. $ Small Cap | 1,50 $ | — | — | 43 | Details › |
| 185 | FATE FATE THERAPEUTICS INC | 248,5 Mio. $ Small Cap | 2,11 $ | — | — | 49 | Details › |
| 186 | ZSQR Z Squared Inc. | 247,6 Mio. $ Small Cap | 3,91 $ | — | — | 24 | Details › |
| 187 | CTNM Contineum Therapeutics, Inc. | 246,7 Mio. $ Small Cap | 8,36 $ | — | — | 51 | Details › |
| 188 | BIOA BioAge Labs, Inc. | 246,1 Mio. $ Small Cap | 5,10 $ | — | — | 48 | Details › |
| 189 | BCYC BICYCLE THERAPEUTICS PLC | 246,0 Mio. $ Small Cap | 3,50 $ | — | — | 40 | Details › |
| 190 | ABEO ABEONA THERAPEUTICS INC. | 245,6 Mio. $ Small Cap | 4,40 $ | 4,4 | — | 48 | Details › |
| 191 | LRMR Larimar Therapeutics, Inc. | 242,2 Mio. $ Small Cap | 2,35 $ | — | — | 32 | Details › |
| 192 | LCTX Lineage Cell Therapeutics, Inc. | 242,2 Mio. $ Small Cap | 1,00 $ | — | — | 45 | Details › |
| 193 | PALI PALISADE BIO, INC. | 241,4 Mio. $ Small Cap | 1,33 $ | — | — | 41 | Details › |
| 194 | VRXA Veraxa Biotech AG - Post de-SPAC | 240,3 Mio. $ Small Cap | 1,00 $ | — | — | 60 | Details › |
| 195 | LAB STANDARD BIOTOOLS INC. | 239,4 Mio. $ Small Cap | 0,61 $ | — | — | 44 | Details › |
| 196 | ACIU AC Immune SA | 238,7 Mio. $ Small Cap | 2,43 $ | — | — | 49 | Details › |
| 197 | EPRX EUPRAXIA PHARMACEUTICALS INC. | 231,3 Mio. $ Small Cap | 6,87 $ | — | — | 44 | Details › |
| 198 | LXEO Lexeo Therapeutics, Inc. | 226,6 Mio. $ Small Cap | 2,78 $ | — | — | 46 | Details › |
| 199 | GUTS FRACTYL HEALTH, INC. | 226,4 Mio. $ Small Cap | 1,08 $ | — | — | 16 | Details › |
| 200 | KROS Keros Therapeutics, Inc. | 217,1 Mio. $ Small Cap | 11,01 $ | 4,8 | — | 73 | Details › |
| 201 | ADCT ADC Therapeutics SA | 217,0 Mio. $ Small Cap | 1,49 $ | — | — | 35 | Details › |
| 202 | IKT Inhibikase Therapeutics, Inc. | 212,7 Mio. $ Small Cap | 1,59 $ | — | — | 57 | Details › |
| 203 | CAMP Camp4 Therapeutics Corp | 210,6 Mio. $ Small Cap | 3,30 $ | — | — | 39 | Details › |
| 204 | LYEL Lyell Immunopharma, Inc. | 209,4 Mio. $ Small Cap | 9,32 $ | — | — | 26 | Details › |
| 205 | CTY CITY THERAPEUTICS, INC. | 205,9 Mio. $ Small Cap | 20,77 $ | — | — | — | Details › |
| 206 | LIMN Liminatus Pharma, Inc. | 204,2 Mio. $ Small Cap | 2,94 $ | — | — | — | Details › |
| 207 | NAGE Niagen Bioscience, Inc. | 201,8 Mio. $ Small Cap | 2,43 $ | 12,6 | — | 52 | Details › |
| 208 | RNAC Cartesian Therapeutics, Inc. | 199,1 Mio. $ Small Cap | 6,18 $ | — | — | 54 | Details › |
| 209 | ETRA Electra Therapeutics, Inc. | 198,3 Mio. $ Small Cap | 8,71 $ | — | — | — | Details › |
| 210 | CGEN COMPUGEN LTD | 179,3 Mio. $ Small Cap | 1,94 $ | 5,2 | — | 53 | Details › |
| 211 | EVMN Evommune, Inc. | 178,1 Mio. $ Small Cap | 5,10 $ | — | — | 40 | Details › |
| 212 | ORMP ORAMED PHARMACEUTICALS INC. | 171,8 Mio. $ Small Cap | 4,13 $ | 2,7 | 6,1 % | 69 | Details › |
| 213 | WHWK Whitehawk Therapeutics, Inc. | 171,4 Mio. $ Small Cap | 3,21 $ | — | — | 44 | Details › |
| 214 | STRO SUTRO BIOPHARMA, INC. | 170,3 Mio. $ Small Cap | 9,33 $ | — | — | 35 | Details › |
| 215 | PEPG PepGen Inc. | 169,7 Mio. $ Small Cap | 2,48 $ | — | — | 37 | Details › |
| 216 | IVA Inventiva S.A. | 168,4 Mio. $ Small Cap | 3,51 $ | — | — | 47 | Details › |
| 217 | SION Sionna Therapeutics, Inc. | 167,5 Mio. $ Small Cap | 3,60 $ | — | — | 28 | Details › |
| 218 | DTIL PRECISION BIOSCIENCES INC | 167,4 Mio. $ Small Cap | 6,73 $ | — | — | 40 | Details › |
| 219 | TRDA Entrada Therapeutics, Inc. | 163,5 Mio. $ Small Cap | 4,56 $ | — | — | 40 | Details › |
| 220 | IMRX Immuneering Corp | 158,1 Mio. $ Small Cap | 3,67 $ | — | — | 41 | Details › |
| 221 | TARA Protara Therapeutics, Inc. | 157,2 Mio. $ Small Cap | 2,39 $ | — | — | 43 | Details › |
| 222 | UPB Upstream Bio, Inc. | 156,0 Mio. $ Small Cap | 2,74 $ | — | — | 44 | Details › |
| 223 | MDCX Medicus Pharma Ltd. | 155,5 Mio. $ Small Cap | 2,50 $ | — | — | 19 | Details › |
| 224 | ALXO ALX ONCOLOGY HOLDINGS INC | 155,1 Mio. $ Small Cap | 1,15 $ | — | — | 41 | Details › |
| 225 | KRRO Korro Bio, Inc. | 154,5 Mio. $ Small Cap | 11,45 $ | — | — | 34 | Details › |
| 226 | NBP NovaBridge Biosciences | 152,4 Mio. $ Small Cap | 1,33 $ | — | — | 26 | Details › |
| 227 | PYXS Pyxis Oncology, Inc. | 144,9 Mio. $ Small Cap | 1,69 $ | — | — | 32 | Details › |
| 228 | ABOS Acumen Pharmaceuticals, Inc. | 144,9 Mio. $ Small Cap | 1,93 $ | — | — | 42 | Details › |
| 229 | KRSA Korsana Biosciences, Inc. | 144,7 Mio. $ Small Cap | 31,31 $ | — | — | 28 | Details › |
| 230 | PRQR ProQR Therapeutics N.V. | 140,3 Mio. $ Small Cap | 1,31 $ | — | — | 46 | Details › |
| 231 | IAM Iambic Therapeutics, Inc. | 139,4 Mio. $ Small Cap | 14,26 $ | — | — | — | Details › |
| 232 | MBRX Moleculin Biotech, Inc. | 138,8 Mio. $ Small Cap | 5,84 $ | — | — | 37 | Details › |
| 233 | RNA Atrium Therapeutics, Inc. | 138,6 Mio. $ Small Cap | 8,20 $ | — | — | 48 | Details › |
| 234 | NKTX Nkarta, Inc. | 136,8 Mio. $ Small Cap | 1,76 $ | — | — | 47 | Details › |
| 235 | IPHA Innate Pharma SA | 134,1 Mio. $ Small Cap | 1,50 $ | — | — | — | Details › |
| 236 | CMPX Compass Therapeutics, Inc. | 133,4 Mio. $ Small Cap | 0,75 $ | — | — | 38 | Details › |
| 237 | ARMP Armata Pharmaceuticals, Inc. | 132,5 Mio. $ Small Cap | 3,64 $ | — | — | 46 | Details › |
| 238 | AVXL ANAVEX LIFE SCIENCES CORP. | 132,1 Mio. $ Small Cap | 1,33 $ | — | — | 29 | Details › |
| 239 | CURX Curanex Pharmaceuticals Inc | 132,0 Mio. $ Small Cap | 4,64 $ | — | — | — | Details › |
| 240 | CDXS CODEXIS, INC. | 124,7 Mio. $ Small Cap | 1,28 $ | — | — | 36 | Details › |
| 241 | TRXB TRex Bio, Inc. | 122,3 Mio. $ Small Cap | 13,81 $ | — | — | — | Details › |
| 242 | SPRB SPRUCE BIOSCIENCES, INC. | 121,9 Mio. $ Small Cap | 44,42 $ | — | — | 38 | Details › |
| 243 | FHTX Foghorn Therapeutics Inc. | 117,1 Mio. $ Small Cap | 2,02 $ | — | — | 33 | Details › |
| 244 | CLLS Cellectis S.A. | 116,8 Mio. $ Small Cap | 1,00 $ | — | — | — | Details › |
| 245 | VYGR Voyager Therapeutics, Inc. | 114,7 Mio. $ Small Cap | 1,77 $ | — | — | 27 | Details › |
| 246 | TNYA Tenaya Therapeutics, Inc. | 111,1 Mio. $ Small Cap | 0,39 $ | — | — | 27 | Details › |
| 247 | FRNM Freenome, Inc. | 111,0 Mio. $ Small Cap | 12,91 $ | — | — | 30 | Details › |
| 248 | GNLX GENELUX Corp | 108,6 Mio. $ Small Cap | 2,00 $ | — | — | 46 | Details › |
| 249 | SEER Seer, Inc. | 108,1 Mio. $ Small Cap | 1,93 $ | — | — | 54 | Details › |
| 250 | OKUR OnKure Therapeutics, Inc. | 107,8 Mio. $ Small Cap | 2,52 $ | — | — | 53 | Details › |
| 251 | UNCY Unicycive Therapeutics, Inc. | 107,8 Mio. $ Small Cap | 3,73 $ | — | — | 21 | Details › |
| 252 | ENGN enGene Therapeutics Inc. | 106,5 Mio. $ Small Cap | 1,56 $ | 0,7 | — | 30 | Details › |
| 253 | MXCT MAXCYTE, INC. | 106,5 Mio. $ Small Cap | 1,40 $ | — | — | 68 | Details › |
| 254 | HURA TuHURA Biosciences, Inc./NV | 105,5 Mio. $ Small Cap | 2,18 $ | — | — | 50 | Details › |
| 255 | VXRT Vaxart, Inc. | 103,8 Mio. $ Small Cap | 0,41 $ | 6,3 | — | 63 | Details › |
| 256 | INO INOVIO PHARMACEUTICALS, INC. | 103,4 Mio. $ Small Cap | 0,90 $ | — | — | 26 | Details › |
| 257 | BDTX Black Diamond Therapeutics, Inc. | 99,9 Mio. $ Small Cap | 1,90 $ | 4,9 | — | 57 | Details › |
| 258 | COYA Coya Therapeutics, Inc. | 98,1 Mio. $ Small Cap | 4,06 $ | — | — | 55 | Details › |
| 259 | PLYX Polaryx Therapeutics, Inc. | 96,5 Mio. $ Small Cap | 1,85 $ | — | — | — | Details › |
| 260 | PYPD PolyPid Ltd. | 95,6 Mio. $ Small Cap | 5,17 $ | — | — | 58 | Details › |
| 261 | IMUX IMMUNIC, INC. | 94,4 Mio. $ Small Cap | 7,41 $ | — | — | 31 | Details › |
| 262 | PROK PROKIDNEY CORP. | 94,4 Mio. $ Small Cap | 1,40 $ | — | — | 30 | Details › |
| 263 | ANIX Anixa Biosciences Inc | 93,4 Mio. $ Small Cap | 2,99 $ | — | — | 62 | Details › |
| 264 | AGPU Axe Compute Inc. | 92,7 Mio. $ Small Cap | 7,77 $ | — | — | 30 | Details › |
| 265 | ATRA Atara Biotherapeutics, Inc. | 91,7 Mio. $ Small Cap | 8,59 $ | 3,7 | — | 51 | Details › |
| 266 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 88,9 Mio. $ Small Cap | 3,99 $ | — | — | 41 | Details › |
| 267 | ADAG Adagene Inc. | 87,8 Mio. $ Small Cap | 2,45 $ | — | — | 62 | Details › |
| 268 | RLYB Rallybio Corp | 87,3 Mio. $ Small Cap | 16,55 $ | — | — | — | Details › |
| 269 | EQ Equillium, Inc. | 76,7 Mio. $ Small Cap | 1,21 $ | — | — | 52 | Details › |
| 270 | PDSB PDS Biotechnology Corp | 76,3 Mio. $ Small Cap | 1,11 $ | — | — | 7 | Details › |
| 271 | CRDF Cardiff Oncology, Inc. | 75,8 Mio. $ Small Cap | 0,91 $ | — | — | 44 | Details › |
| 272 | OKYO OKYO Pharma Ltd | 74,8 Mio. $ Small Cap | 1,44 $ | — | — | — | Details › |
| 273 | CING Cingulate Inc. | 74,2 Mio. $ Small Cap | 4,75 $ | — | — | 42 | Details › |
| 274 | MAIA MAIA Biotechnology, Inc. | 73,4 Mio. $ Small Cap | 1,15 $ | — | — | 42 | Details › |
| 275 | RFL Rafael Holdings, Inc. | 73,0 Mio. $ Small Cap | 1,32 $ | — | — | — | Details › |
| 276 | CGTX COGNITION THERAPEUTICS INC | 71,9 Mio. $ Small Cap | 0,72 $ | — | — | 49 | Details › |
| 277 | LEXX Lexaria Bioscience Corp. | 71,7 Mio. $ Small Cap | 3,08 $ | — | — | 24 | Details › |
| 278 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | 71,7 Mio. $ Small Cap | 3,27 $ | — | — | 35 | Details › |
| 279 | PMN ProMIS Neurosciences Inc. | 70,3 Mio. $ Small Cap | 8,34 $ | — | — | 44 | Details › |
| 280 | NMRA Neumora Therapeutics, Inc. | 70,3 Mio. $ Small Cap | 0,37 $ | — | — | 44 | Details › |
| 281 | MNOV MEDICINOVA INC | 70,2 Mio. $ Small Cap | 1,39 $ | — | — | 29 | Details › |
| 282 | NTRB NutriBand Inc. | 69,5 Mio. $ Small Cap | 5,57 $ | — | — | 36 | Details › |
| 283 | APLM Apollomics Inc. | 67,8 Mio. $ Small Cap | 22,44 $ | — | — | — | Details › |
| 284 | FBIO Fortress Biotech, Inc. | 67,7 Mio. $ Small Cap | 1,93 $ | — | — | 49 | Details › |
| 285 | NMAD NOMAD POWER SOLUTIONS, INC. | 65,6 Mio. $ Small Cap | 3,55 $ | — | — | 46 | Details › |
| 286 | TLSA Tiziana Life Sciences Ltd | 63,8 Mio. $ Small Cap | 0,96 $ | — | — | 48 | Details › |
| 287 | CRBU Caribou Biosciences, Inc. | 62,6 Mio. $ Small Cap | 0,57 $ | — | — | 20 | Details › |
| 288 | XBIT XBiotech Inc. | 62,3 Mio. $ Small Cap | 1,90 $ | — | — | 48 | Details › |
| 289 | LONA LeonaBio, Inc. | 60,3 Mio. $ Small Cap | 5,12 $ | — | — | 45 | Details › |
| 290 | OSTX OS Therapies Inc | 58,7 Mio. $ Small Cap | 1,25 $ | — | — | 38 | Details › |
| 291 | GANX Gain Therapeutics, Inc. | 58,3 Mio. $ Small Cap | 1,26 $ | — | — | 50 | Details › |
| 292 | INKT MiNK Therapeutics, Inc. | 57,8 Mio. $ Small Cap | 11,00 $ | — | — | 54 | Details › |
| 293 | HRTX HERON THERAPEUTICS, INC. /DE/ | 56,6 Mio. $ Small Cap | 0,30 $ | — | — | 30 | Details › |
| 294 | BOLD Boundless Bio, Inc. | 56,1 Mio. $ Small Cap | 2,39 $ | — | — | 59 | Details › |
| 295 | ONCY ONCOLYTICS BIOTECH INC | 55,8 Mio. $ Small Cap | 0,50 $ | — | — | 35 | Details › |
| 296 | ALDX Aldeyra Therapeutics, Inc. | 54,8 Mio. $ Small Cap | 0,65 $ | — | — | 37 | Details › |
| 297 | XLO Xilio Therapeutics, Inc. | 53,6 Mio. $ Small Cap | 7,97 $ | — | — | — | Details › |
| 298 | SDEV Stablecoin Development Corp | 53,6 Mio. $ Small Cap | 1,09 $ | — | 1.888,8 % | 28 | Details › |
| 299 | RNXT RenovoRx, Inc. | 53,1 Mio. $ Small Cap | 1,29 $ | — | — | 46 | Details › |
| 300 | HYFT MindWalk Holdings Corp. | 52,2 Mio. $ Small Cap | 1,14 $ | — | — | 57 | Details › |
| 301 | PLRX PLIANT THERAPEUTICS, INC. | 52,1 Mio. $ Small Cap | 0,84 $ | — | — | 54 | Details › |
| 302 | IBIO iBio, Inc. | 49,6 Mio. $ Micro Cap | 0,72 $ | — | — | 38 | Details › |
| 303 | HOWL Werewolf Therapeutics, Inc. | 49,5 Mio. $ Micro Cap | 1,03 $ | — | — | 47 | Details › |
| 304 | KLRS Kalaris Therapeutics, Inc. | 48,7 Mio. $ Micro Cap | 2,01 $ | — | — | 33 | Details › |
| 305 | ELTX Elicio Therapeutics, Inc. | 48,0 Mio. $ Micro Cap | 1,94 $ | — | — | 36 | Details › |
| 306 | SER Serina Therapeutics, Inc. | 46,8 Mio. $ Micro Cap | 1,74 $ | — | — | — | Details › |
| 307 | BSEM BioStem Technologies, Inc. | 43,8 Mio. $ Micro Cap | 1,64 $ | — | — | 43 | Details › |
| 308 | INMB Inmune Bio, Inc. | 43,5 Mio. $ Micro Cap | 1,51 $ | — | — | 51 | Details › |
| 309 | ANVS Annovis Bio, Inc. | 43,5 Mio. $ Micro Cap | 1,00 $ | — | — | 46 | Details › |
| 310 | RANI Rani Therapeutics Holdings, Inc. | 43,0 Mio. $ Micro Cap | 0,60 $ | — | — | 37 | Details › |
| 311 | DWTX Dogwood Therapeutics, Inc. | 41,0 Mio. $ Micro Cap | 1,16 $ | — | — | — | Details › |
| 312 | CALC CalciMedica, Inc. | 41,0 Mio. $ Micro Cap | 1,22 $ | — | — | — | Details › |
| 313 | BRTX BioRestorative Therapies, Inc. | 40,8 Mio. $ Micro Cap | 1,62 $ | — | — | — | Details › |
| 314 | ACET Adicet Bio, Inc. | 39,1 Mio. $ Micro Cap | 4,17 $ | — | — | 38 | Details › |
| 315 | SCYX SCYNEXIS INC | 38,9 Mio. $ Micro Cap | 3,79 $ | — | — | 44 | Details › |
| 316 | TIL Instil Bio, Inc. | 38,8 Mio. $ Micro Cap | 5,68 $ | — | — | 22 | Details › |
| 317 | LGVN Longeveron Inc. | 38,8 Mio. $ Micro Cap | 1,54 $ | — | — | 13 | Details › |
| 318 | GRDX GridAI Technologies Corp. | 36,2 Mio. $ Micro Cap | 5,48 $ | — | — | 44 | Details › |
| 319 | VERU VERU INC. | 35,1 Mio. $ Micro Cap | 2,24 $ | — | — | 53 | Details › |
| 320 | ESLA Estrella Immunopharma, Inc. | 34,7 Mio. $ Micro Cap | 0,80 $ | — | — | — | Details › |
| 321 | IRLA IRulya Therapeutics Inc. | 34,2 Mio. $ Micro Cap | 33,08 $ | — | — | 26 | Details › |
| 322 | LITS Lite Strategy, Inc. | 33,6 Mio. $ Micro Cap | 1,16 $ | — | — | 44 | Details › |
| 323 | FLNA FILANA THERAPEUTICS, INC. | 33,3 Mio. $ Micro Cap | 0,64 $ | — | — | 31 | Details › |
| 324 | CRVO CervoMed Inc. | 32,7 Mio. $ Micro Cap | 2,31 $ | — | — | 43 | Details › |
| 325 | MGX Metagenomi Therapeutics, Inc. | 32,5 Mio. $ Micro Cap | 0,79 $ | — | — | 35 | Details › |
| 326 | CELU Celularity Inc | 32,1 Mio. $ Micro Cap | 0,98 $ | — | — | — | Details › |
| 327 | ALGS Aligos Therapeutics, Inc. | 30,3 Mio. $ Micro Cap | 4,76 $ | — | — | 34 | Details › |
| 328 | ATOS ATOSSA THERAPEUTICS, INC. | 29,9 Mio. $ Micro Cap | 2,60 $ | — | — | 41 | Details › |
| 329 | TAOX TAO Synergies Inc. | 29,0 Mio. $ Micro Cap | 3,31 $ | — | — | 32 | Details › |
| 330 | CVM CEL SCI CORP | 28,9 Mio. $ Micro Cap | 1,64 $ | — | — | 39 | Details › |
| 331 | BCTX BriaCell Therapeutics Corp. | 28,7 Mio. $ Micro Cap | 3,47 $ | — | — | 40 | Details › |
| 332 | RNAZ Transcode Therapeutics, Inc. | 28,0 Mio. $ Micro Cap | 1,77 $ | — | — | — | Details › |
| 333 | TCRX TScan Therapeutics, Inc. | 24,8 Mio. $ Micro Cap | 0,21 $ | — | — | 19 | Details › |
| 334 | IMMP IMMUTEP Ltd | 24,7 Mio. $ Micro Cap | 3,20 $ | — | — | — | Details › |
| 335 | EVAX Evaxion A/S | 23,7 Mio. $ Micro Cap | 3,75 $ | — | — | 56 | Details › |
| 336 | BIAF bioAffinity Technologies, Inc. | 23,5 Mio. $ Micro Cap | 2,98 $ | — | — | 29 | Details › |
| 337 | NXTC NextCure, Inc. | 21,6 Mio. $ Micro Cap | 4,68 $ | — | — | 30 | Details › |
| 338 | MCRB Seres Therapeutics, Inc. | 21,4 Mio. $ Micro Cap | 2,11 $ | 3,3 | — | 51 | Details › |
| 339 | BYSI BeyondSpring Inc. | 20,7 Mio. $ Micro Cap | 0,44 $ | — | — | — | Details › |
| 340 | NEUP Neuphoria Therapeutics Inc. | 19,1 Mio. $ Micro Cap | 3,44 $ | — | — | — | Details › |
| 341 | KZIA KAZIA THERAPEUTICS LTD | 18,2 Mio. $ Micro Cap | 7,81 $ | — | — | 35 | Details › |
| 342 | MRKR Marker Therapeutics, Inc. | 15,4 Mio. $ Micro Cap | 0,96 $ | — | — | 39 | Details › |
| 343 | JSPR Jasper Therapeutics, Inc. | 15,1 Mio. $ Micro Cap | 0,49 $ | — | — | 3 | Details › |
| 344 | BCDA BioCardia, Inc. | 15,1 Mio. $ Micro Cap | 0,92 $ | — | — | 47 | Details › |
| 345 | ALLR Allarity Therapeutics, Inc. | 14,5 Mio. $ Micro Cap | 0,87 $ | — | — | — | Details › |
| 346 | QNTM Quantum Biopharma Ltd. | 14,4 Mio. $ Micro Cap | 2,29 $ | — | — | 37 | Details › |
| 347 | TVRD Tvardi Therapeutics, Inc. | 14,3 Mio. $ Micro Cap | 0,94 $ | — | — | 30 | Details › |
| 348 | ARTL ARTELO BIOSCIENCES, INC. | 13,2 Mio. $ Micro Cap | 2,55 $ | — | — | — | Details › |
| 349 | BOLT Bolt Biotherapeutics, Inc. | 13,2 Mio. $ Micro Cap | 6,83 $ | — | — | — | Details › |
| 350 | CMMB Chemomab Therapeutics Ltd. | 12,7 Mio. $ Micro Cap | 1,03 $ | 8,9 | — | — | Details › |
| 351 | PLRZ Polyrizon Ltd. | 12,0 Mio. $ Micro Cap | 8,73 $ | — | — | — | Details › |
| 352 | LPCN Lipocine Inc. | 11,7 Mio. $ Micro Cap | 1,42 $ | — | — | 44 | Details › |
| 353 | MSLE Satellos Bioscience Inc. | 11,6 Mio. $ Micro Cap | 6,42 $ | — | — | 52 | Details › |
| 354 | TCRT Alaunos Therapeutics, Inc. | 11,4 Mio. $ Micro Cap | 2,36 $ | — | — | 2 | Details › |
| 355 | INTS INTENSITY THERAPEUTICS, INC. | 11,2 Mio. $ Micro Cap | 3,25 $ | — | — | — | Details › |
| 356 | PASG Passage BIO, Inc. | 11,0 Mio. $ Micro Cap | 3,37 $ | — | — | — | Details › |
| 357 | MTVA MetaVia Inc. | 10,6 Mio. $ Micro Cap | 1,38 $ | — | — | — | Details › |
| 358 | INAB IN8BIO, INC. | 10,4 Mio. $ Micro Cap | 1,05 $ | — | — | — | Details › |
| 359 | DARE Dare Bioscience, Inc. | 10,3 Mio. $ Micro Cap | 0,65 $ | — | — | — | Details › |
| 360 | TOVX Theriva Biologics, Inc. | 9,3 Mio. $ Micro Cap | 0,20 $ | — | — | — | Details › |
| 361 | XCUR EXICURE, INC. | 9,2 Mio. $ Micro Cap | 1,05 $ | — | — | — | Details › |
| 362 | BIVI BIOVIE INC. | 8,8 Mio. $ Micro Cap | 1,24 $ | — | — | 43 | Details › |
| 363 | LSTA LISATA THERAPEUTICS, INC. | 8,8 Mio. $ Micro Cap | 1,00 $ | — | — | 15 | Details › |
| 364 | VTGN Vistagen Therapeutics, Inc. | 8,4 Mio. $ Micro Cap | 0,18 $ | — | — | 18 | Details › |
| 365 | LTRN Lantern Pharma Inc. | 8,1 Mio. $ Micro Cap | 0,60 $ | — | — | 33 | Details › |
| 366 | ACTU ACTUATE THERAPEUTICS, INC. | 7,5 Mio. $ Micro Cap | 0,46 $ | — | — | 29 | Details › |
| 367 | IMRN Immuron Ltd | 6,9 Mio. $ Micro Cap | 0,99 $ | — | — | — | Details › |
| 368 | NRSN NeuroSense Therapeutics Ltd. | 6,6 Mio. $ Micro Cap | 2,42 $ | — | — | — | Details › |
| 369 | APRE Aprea Therapeutics, Inc. | 6,5 Mio. $ Micro Cap | 0,53 $ | — | — | — | Details › |
| 370 | FBLG FibroBiologics, Inc. | 6,5 Mio. $ Micro Cap | 0,98 $ | — | — | — | Details › |
| 371 | NCNA NuCana plc | 6,2 Mio. $ Micro Cap | 0,99 $ | — | — | — | Details › |
| 372 | IMNN Imunon, Inc. | 6,0 Mio. $ Micro Cap | 1,24 $ | — | — | — | Details › |
| 373 | ALZN Alzamend Neuro, Inc. | 5,6 Mio. $ Micro Cap | 1,13 $ | — | — | — | Details › |
| 374 | SNTI Senti Biosciences Holdings, Inc. | 5,6 Mio. $ Micro Cap | 0,19 $ | — | — | — | Details › |
| 375 | CLGN CollPlant Biotechnologies Ltd | 5,6 Mio. $ Micro Cap | 3,64 $ | — | — | — | Details › |
| 376 | INBS INTELLIGENT BIO SOLUTIONS INC. | 5,4 Mio. $ Micro Cap | 1,68 $ | — | — | — | Details › |
| 377 | PCSA Processa Pharmaceuticals, Inc. | 5,4 Mio. $ Micro Cap | 1,81 $ | — | — | — | Details › |
| 378 | CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | 5,3 Mio. $ Micro Cap | 0,74 $ | — | — | — | Details › |
| 379 | KALA KALA BIO, Inc. | 4,8 Mio. $ Micro Cap | 0,19 $ | — | — | 19 | Details › |
| 380 | DRMA Dermata Therapeutics, Inc. | 4,6 Mio. $ Micro Cap | 0,78 $ | — | — | — | Details › |
| 381 | AZTR Azitra, Inc. | 4,3 Mio. $ Micro Cap | 0,07 $ | — | — | — | Details › |
| 382 | NIKI Niki BioSolutions, Inc. | 4,0 Mio. $ Micro Cap | 1,83 $ | — | — | — | Details › |
| 383 | ERNA Ernexa Therapeutics Inc. | 3,7 Mio. $ Micro Cap | 2,07 $ | — | — | — | Details › |
| 384 | GRI GRI Bio, Inc. | 3,6 Mio. $ Micro Cap | 1,50 $ | — | — | — | Details › |
| 385 | ENLV Enlivex Ltd. | 3,0 Mio. $ Micro Cap | 0,17 $ | 0,0 | — | 22 | Details › |
| 386 | APVO Aptevo Therapeutics Inc. | 3,0 Mio. $ Micro Cap | 1,61 $ | — | — | — | Details › |
| 387 | LNAI Lunai Bioworks Inc. | 2,6 Mio. $ Micro Cap | 0,29 $ | — | — | — | Details › |
| 388 | VIVS VivoSim Labs, INC. | 2,4 Mio. $ Micro Cap | 0,15 $ | — | — | 8 | Details › |
| 389 | CANF Can-Fite BioPharma Ltd. | 2,3 Mio. $ Micro Cap | 1,78 $ | — | — | — | Details › |
| 390 | HCWB HCW Biologics Inc. | 2,1 Mio. $ Micro Cap | 1,11 $ | — | — | — | Details › |
| 391 | SILO Silo Pharma, Inc. | 2,0 Mio. $ Micro Cap | 1,18 $ | — | — | — | Details › |
| 392 | GNPX Genprex, Inc. | 1,9 Mio. $ Micro Cap | 1,81 $ | — | — | 23 | Details › |
| 393 | VRAX Virax Biolabs Group Ltd | 1,7 Mio. $ Micro Cap | 1,26 $ | — | — | — | Details › |
| 394 | GOVX GeoVax Labs, Inc. | 1,5 Mio. $ Micro Cap | 0,21 $ | — | — | — | Details › |
| 395 | MLEC Moolec Science SA | 1,2 Mio. $ Micro Cap | 1,69 $ | — | — | — | Details › |
| 396 | CRIS CURIS INC | 1,1 Mio. $ Micro Cap | 0,39 $ | — | — | 16 | Details › |
| 397 | SLXN Silexion Therapeutics Corp | 816.783 $ Micro Cap | 0,19 $ | 0,0 | — | 5 | Details › |
| 398 | DCOY Decoy Therapeutics Inc. | 724.834 $ Micro Cap | 1,03 $ | — | — | — | Details › |
| 399 | SBFM Sunshine Biopharma Inc. | 623.258 $ Micro Cap | 0,15 $ | — | — | 13 | Details › |
| 400 | RKDA Arcadia Biosciences, Inc. | 425.094 $ Micro Cap | 0,16 $ | — | — | 9 | Details › |
| 401 | BDRX Biodexa Pharmaceuticals Plc | 373.229 $ Micro Cap | 0,41 $ | — | — | 21 | Details › |
| 402 | STKH Steakholder Foods Ltd. | 287.580 $ Micro Cap | 0,45 $ | — | — | — | Details › |
| 403 | CDT CDT Equity Inc. | 247.433 $ Micro Cap | 0,14 $ | — | — | -6 | Details › |
| 404 | XRTX XORTX Therapeutics Inc. | 220.905 $ Micro Cap | 0,94 $ | — | — | — | Details › |
| 405 | SPRC SciSparc Ltd. | 151.826 $ Micro Cap | 1,20 $ | — | — | — | Details › |
| 406 | LYCA Lycia Therapeutics, Inc. | — Micro Cap | 30,00 $ | — | — | — | Details › |
| 407 | SCTX Scribe Therapeutics, Inc. | — Micro Cap | 15,41 $ | — | — | — | Details › |